Aura Biosciences, Inc. (AURA) stock
AURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$7.11+0.00 (0.00%)
Close on Nov 13, 2026Market cap $737.34MP/E –Yield –
Aura Biosciences total assets
Total assets on the balance sheet at the end of each period.
Aura Biosciences's total assets was $321.62M at Sep 30, 2026. For fiscal 2025 it was $169.43M, down 7.2% from the year before. The highest annual figure on record is $255.08M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $169.43M | -7.2% |
| FY2024 | Dec 31, 2024 | $182.50M | -28.5% |
| FY2023 | Dec 31, 2023 | $255.08M | +13.9% |
| FY2022 | Dec 31, 2022 | $223.94M | +39.9% |
| FY2021 | Dec 31, 2021 | $160.03M | +624.0% |
| FY2020 | Dec 31, 2020 | $22.10M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $321.62M | +69.3% |
| Q2 FY2026 | Jun 30, 2026 | $348.13M | +70.3% |
| Q1 FY2026 | Mar 31, 2026 | $137.68M | -11.4% |
| Q4 FY2025 | Dec 31, 2025 | $169.43M | -7.2% |
| Q3 FY2025 | Sep 30, 2025 | $190.02M | -7.5% |
| Q2 FY2025 | Jun 30, 2025 | $204.40M | -6.4% |
| Q1 FY2025 | Mar 31, 2025 | $155.40M | -33.9% |
| Q4 FY2024 | Dec 31, 2024 | $182.50M | -28.5% |
| Q3 FY2024 | Sep 30, 2024 | $205.34M | +14.2% |
| Q2 FY2024 | Jun 30, 2024 | $218.28M | +13.3% |
| Q1 FY2024 | Mar 31, 2024 | $235.03M | +14.1% |
| Q4 FY2023 | Dec 31, 2023 | $255.08M | +13.9% |
| Q3 FY2023 | Sep 30, 2023 | $179.77M | +25.6% |
| Q2 FY2023 | Jun 30, 2023 | $192.74M | +42.7% |
| Q1 FY2023 | Mar 31, 2023 | $206.02M | +40.7% |
| Q4 FY2022 | Dec 31, 2022 | $223.94M | +39.9% |
| Q3 FY2022 | Sep 30, 2022 | $143.15M | +57.8% |
| Q2 FY2022 | Jun 30, 2022 | $135.02M | +510.8% |
| Q1 FY2022 | Mar 31, 2022 | $146.42M | – |
| Q4 FY2021 | Dec 31, 2021 | $160.03M | – |
| Q3 FY2021 | Sep 30, 2021 | $90.70M | – |
| Q4 FY2020 | Dec 31, 2020 | $22.10M | – |
See a number that looks wrong?